22
Views
35
CrossRef citations to date
0
Altmetric
Original Articles

Neurodynamics of Relapse Prevention: A Neuronutrient Approach to Outpatient DUI Offenders

, &
Pages 173-187 | Published online: 20 Jan 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (13)

Kenneth Blum, Bruce Steinberg, Marjorie C Gondre-Lewis, David Baron, Edward J Modestino, Rajendra D Badgaiyan, B William Downs, Debasis Bagchi, Raymond Brewer, Thomas McLaughlin, Abdalla Bowirrat & Mark Gold. (2021) A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing “Precision Behavioral Management”. Psychology Research and Behavior Management 14, pages 2115-2134.
Read now
Mark S. Gold, Kenneth Blum, Marlene Oscar–Berman & Eric R. Braverman. (2014) Low Dopamine Function in Attention Deficit/Hyperactivity Disorder: Should Genotyping Signify Early Diagnosis in Children?. Postgraduate Medicine 126:1, pages 153-177.
Read now
Rachel Harrison, Julia J. Rucklidge & Neville Blampied. (2013) Use of Micronutrients Attenuates Cannabis and Nicotine Abuse as Evidenced From a Reversal Design: A Case Study. Journal of Psychoactive Drugs 45:2, pages 168-178.
Read now
Julia J Rucklidge & Bonnie J Kaplan. (2013) Broad-spectrum micronutrient formulas for the treatment of psychiatric symptoms: a systematic review. Expert Review of Neurotherapeutics 13:1, pages 49-73.
Read now
Merlene Miller, Amanda LC Chen, Stan D. Stokes, Susan Silverman, Abdalla Bowirrat, Matthew Manka, Debra Manka, David K. Miller, Kenneth Perrine, Thomas JH Chen, John A. Bailey, William Downs, Roger L. Waite, Margaret A. Madigan, Eric R. Braverman, Uma Damle, Mallory Kerner, John Giordano, Siobhan Morse, Marlene Oscar-Berman, Debmalya Barh & Kenneth Blum. (2012) Early Intervention of Intravenous KB220IV- Neuroadaptagen Amino-Acid Therapy (NAAT)™ Improves Behavioral Outcomes in a Residential Addiction Treatment Program: A Pilot Study. Journal of Psychoactive Drugs 44:5, pages 398-409.
Read now
Thomas J.H. Chen, Kenneth Blum, Amanda L.C. Chen, Abdalla Bowirrat, William B. Downs, Margret A. Madigan, Roger L. Waite, John A. Bailey, Mallory Kerner, Swetha Yeldandi, Neil Majmundar, John Giordano, Siohban Morse, David Miller, Frank Fornari & Eric R. Braverman. (2011) Neurogenetics and Clinical Evidence for the Putative Activation of the Brain Reward Circuitry by a Neuroadaptagen: Proposing an Addiction Candidate Gene Panel Map. Journal of Psychoactive Drugs 43:2, pages 108-127.
Read now
Kenneth Blum, Thomas J. H. Chen, Siobhan Morse, John Giordano, Amanda Lih Chaun Chen, James Thompson, Cameron Allen, Andrew Smolen, Joel Lubar, Eric Stice, B. William Downs, Roger L. Waite, Margaret A. Madigan, Mallory Kerner, Frank Fornari & Eric R. Braverman. (2010) Overcoming qEEG Abnormalities and Reward Gene Deficits during Protracted Abstinence in Male Psychostimulant and Polydrug Abusers Utilizing Putative Dopamine D2 Agonist Therapy: Part 2. Postgraduate Medicine 122:6, pages 214-226.
Read now
David K. Miller, Abdalla Bowirrat, Matthew Manka, Merlene Miller, Stanley Stokes, Debra Manka, Cameron Allen, Charles Gant, B. William Downs, Andrew Smolen, Emily Stevens, Swetha Yeldandi & Kenneth Blum. (2010) Acute Intravenous Synaptamine Complex Variant KB220™ “Normalizes” Neurological Dysregulation in Patients during Protracted Abstinence from Alcohol and Opiates as Observed Using Quantitative Electroencephalographic and Genetic Analysis for Reward Polymorphisms: Part 1, Pilot Study with 2 Case Reports. Postgraduate Medicine 122:6, pages 188-213.
Read now
Kenneth Blum, Thomas J.H. Chen, B. William Downs, Abdalla Bowirrat, Roger L. Waite, Eric R. Braverman, Margaret Madigan, Marlene Oscar-Berman, Nicholas DiNubile, Eric Stice, John Giordano, Siobhan Morse & Mark Gold. (2009) Neurogenetics of Dopaminergic Receptor Supersensitivity in Activation of Brain Reward Circuitry and Relapse: Proposing “Deprivation-Amplification Relapse Therapy” (DART). Postgraduate Medicine 121:6, pages 176-196.
Read now
Kenneth Blum, EricR. Braverman, JayM. Holder, JoelF. Lubar, VincentJ. Monastra, David Miller, JudithO. Lubar, ThomasJ.H. Chen & DavidE. Comings. (2000) The Reward Deficiency Syndrome: A Biogenetic Model for the Diagnosis and Treatment of Impulsive, Addictive and Compulsive Behaviors. Journal of Psychoactive Drugs 32:sup1, pages 1-112.
Read now
Deborah S. Finnell. (2000) The Case for Teaching Patients About the Neurobiological Basis of Addictions. Journal of Addictions Nursing 12:3-4, pages 149-158.
Read now
GanttP. Galloway, S.L. Frederick, Scott Thomas, Greg Hayner, FrankE. Staggers, WendyO. Wiehl, Elizabeth Sajo, Diana Amodia & Pablo Stewart. (1996) A Historically Controlled Trial of Tyrosine for Cocaine Dependence. Journal of Psychoactive Drugs 28:3, pages 305-309.
Read now
JaneM. Ussher, Christopher Dewberry, Helen Malson & Julia Noakes. (1995) The relationship between health related quality of life and dietary supplementation in british middle managers: A double blind placebo controlled study. Psychology & Health 10:2, pages 97-111.
Read now

Articles from other publishers (22)

Mauro Ceccanti, Kenneth Blum, Abdalla Bowirrat, Catherine A. Dennen, Eric R. Braverman, David Baron, Thomas Mclaughlin, John Giordano, Ashim Gupta, Bernard W. Downs, Debasis Bagchi, Debmalya Barh, Igor Elman, Panayotis K. Thanos, Rajendra D. Badgaiyan, Drew Edwards & Mark S. Gold. (2022) Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids. Journal of Personalized Medicine 12:12, pages 2015.
Crossref
Kenneth Blum, Catherine A. Dennen, Igor Elman, Abdalla Bowirrat, Panayotis K. Thanos, Rajendra D. Badgaiyan, B. William Downs, Debasis Bagchi, David Baron, Eric R. Braverman, Ashim Gupta, Richard Green, Thomas McLaughlin, Debmalya Barh & Mark S. Gold. (2022) Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?. Journal of Personalized Medicine 12:10, pages 1719.
Crossref
Kenneth Blum, Mark Brodie, Subhash Pandey, Jean Cadet, Ashim Gupta, Igor Elman, Panayotis Thanos, Marjorie Gondre-Lewis, David Baron, Shan Kazmi, Abdalla Bowirrat, Marcelo Febo, Rajendra Badgaiyan, Eric Braverman, Catherine Dennen & Mark Gold. (2022) Researching Mitigation of Alcohol Binge Drinking in Polydrug Abuse: KCNK13 and RASGRF2 Gene(s) Risk Polymorphisms Coupled with Genetic Addiction Risk Severity (GARS) Guiding Precision Pro-Dopamine Regulation. Journal of Personalized Medicine 12:6, pages 1009.
Crossref
Margaret A. Madigan, Ashim Gupta, Abdalla Bowirrat, David Baron, Rajendra D. Badgaiyan, Igor Elman, Catherine A. Dennen, Eric R. Braverman, Mark S. Gold & Kenneth Blum. (2022) Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence?. International Journal of Environmental Research and Public Health 19:11, pages 6395.
Crossref
Kenneth Blum, Abdalla Bowirrat, Eric R. Braverman, David Baron, Jean Lud Cadet, Shan Kazmi, Igor Elman, Panyotis K. Thanos, Rajendra D. Badgaiyan, William B. Downs, Debasis Bagchi, Luis Llanos-Gomez & Mark S. Gold. (2021) Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions. International Journal of Environmental Research and Public Health 18:21, pages 11529.
Crossref
Kenneth Blum, Jag Khalsa, Jean Lud Cadet, David Baron, Abdalla Bowirrat, Brent Boyett, Lisa Lott, Raymond Brewer, Marjorie Gondré-Lewis, Gregory Bunt, Shan Kazmi & Mark S. Gold. (2021) Cannabis-Induced Hypodopaminergic Anhedonia and Cognitive Decline in Humans: Embracing Putative Induction of Dopamine Homeostasis. Frontiers in Psychiatry 12.
Crossref
Kenneth Blum, Jean Lud Cadet & Mark S. Gold. (2021) Psychostimulant use disorder emphasizing methamphetamine and the opioid -dopamine connection: Digging out of a hypodopaminergic ditch. Journal of the Neurological Sciences 420, pages 117252.
Crossref
Julia J. Rucklidge & Roger T. Mulder. (2016) Could nutrition help behaviours associated with personality disorders? A narrative review. Personality and Mental Health 10:1, pages 3-11.
Crossref
Bonnie J. Kaplan, Julia J. Rucklidge, Amy Romijn & Kevin McLeod. (2015) The Emerging Field of Nutritional Mental Health. Clinical Psychological Science 3:6, pages 964-980.
Crossref
Mark S. Gold, Rajendra D. Badgaiyan & Kenneth Blum. (2015) A Shared Molecular and Genetic Basis for Food and Drug Addiction. Psychiatric Clinics of North America 38:3, pages 419-462.
Crossref
Charles W. Popper. (2014) Single-Micronutrient and Broad-Spectrum Micronutrient Approaches for Treating Mood Disorders in Youth and Adults. Child and Adolescent Psychiatric Clinics of North America 23:3, pages 591-672.
Crossref
Kenneth Blum, Thomas Simpaatico, Roger L. Waite, Seth H. Blum, Kristina Dushaj, Margaret A. Madigan, Eric R. Braverman & Marlene Oscar-Bermanm. (2014) Hypothesizing “Reward” Gene Polymorphisms May Predict High Rates of Injury and Addiction in the Workforce: A Nutrient and Electrotherapeutic Based Solution. Health 06:16, pages 2261-2285.
Crossref
Kenneth Blum, David Han, John Giordano, Raquel Lohmann, Eric R. Braverman, Margaret A. Madigan, Debmalya Barh, John Femino, Mary Hauser, B. W. Downs & Thomas Simpatico. 2013. Omics for Personalized Medicine. Omics for Personalized Medicine 365 398 .
Kenneth Blum & Mark S. Gold. (2011) Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: A hypothesis. Medical Hypotheses 76:4, pages 576-584.
Crossref
Margherita Grotzkyj‐Giorgi. (2009) Nutrition and addiction — can dietary changes assist with recovery?. Drugs and Alcohol Today 9:2, pages 24-28.
Crossref
Kenneth Blum, Amanda LihChuan Chen, Thomas JH Chen, Eric R Braverman, Jeffrey Reinking, Seth H Blum, Kimberly Cassel, Bernard W Downs, Roger L Waite, Lonna Williams, Thomas J Prihoda, Mallory M Kerner, Tomas Palomo, David E Comings, Howard Tung, Patrick Rhoades & Marlene Oscar-Berman. (2008) Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary. Theoretical Biology and Medical Modelling 5:1.
Crossref
Thomas J. H. Chen, Kenneth Blum, Roger L. Waite, Brian Meshkin, John Schoolfield, B. Williams Downs, Eric E. Braverman, Vanessa Arcuri, Michael Varshavskiy, Seth H. Blum, Julie Mengucci, Carolyn Reuben & Tomas Palomo. (2007) Gene Narcotic Attenuation Program attenuates substance use disorder, a clinical subtype of reward deficiency syndrome. Advances in Therapy 24:2, pages 402-414.
Crossref
Kenneth Blum .Thomas J.H. Chen .B.W. Downs .Brian Meshkin .Seth H. Blum .Manuel Martinez Pons .Julie F. Mengucci .Roger L. Waite .Vanessa Arcuri .Michael Varshofsiky .Eric R. Braverman .. (2007) Synaptamine (SG8839),TM An Amino-Acid Enkephalinase Inhibition Nutraceutical Improves Recovery of Alcoholics, A Subtype of Reward Deficiency Syndrome (RDS). Trends in Applied Sciences Research 2:2, pages 132-138.
Crossref
Kenneth Blum, Thomas J.H. Chen, Brian Meshkin, Roger L. Waite, B. William Downs, Seth H. Blum, Julie F. Mengucci, Vanessa Arcuri, Eric R. Braverman & Tomas Palomo. (2007) Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: A hypothesis. Medical Hypotheses 69:5, pages 1054-1060.
Crossref
Kenneth Blum, John G. Cull, Thomas J.H. Chen, Susan Garcia-Swan, Jay M. Holder, Robert Wood, Eric R. Braverman, Luke R. Bucci & Michael G. Trachtenberg. (1997) Clinical evidence for effectiveness of Phencal™ in maintaining weight loss in an open-label, controlled, 2-year study. Current Therapeutic Research 58:10, pages 745-763.
Crossref
P. Joseph Frawley & James W. Smith. (1992) One-year follow-up after multimodal inpatient treatment for cocaine and methamphetamine dependecies. Journal of Substance Abuse Treatment 9:4, pages 271-286.
Crossref
Barbara C. Wallace. 1992. Drug Abuse Treatment. Drug Abuse Treatment 175 203 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.